title: Susceptibility to pristane-induced arthritis is altered with changes in bowel flora.
abstract: Pristane-induced arthritis (PIA) is unique among the animal arthritides in that a non-infectious, non-antigenic oil induces a chronic immune based arthritis with a prolonged delay between exposure to the inciting agent and development of the disease. Mice with pristane-induced arthritis have elevated T cell and humoral responses to the 65 kDa heat shock protein derived from Mycobacterium bovis (hsp65) and in common with several other models of autoimmune diseases the incidence of PIA is markedly suppressed by preimmunisation with hsp65 in Freund's incomplete adjuvant (Thompson et al. (1990) Eur. J. Immunol. 20, 2479). Recent studies have investigated how autoimmune reactions to heat shock proteins are involved in the development of arthritis. Arthritic CBA/Igb mice given pristane alone develop antibodies to both hsp65 and GroEl (bacterial 60 kDa heat shock proteins) and to hsp58 (the mammalian equivalent). Moreover, the splenic T cells of such mice proliferate vigorously in response to both bacterial and mammalian 60 kDa heat shock proteins. Remarkably, the anti-hsp65 antibody response in normal mice rises rapidly with age, directly correlating with the age related incidence of PIA. In addition, specific pathogen free mice (SPF) maintained in an isolator have negligible anti-hsp65 responses but these convert to positive responses if the animals are exposed to the open part of the animal facility (Thompson et al. (1992) Arthritis Rheum. 35, 139).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, UK.
authors.forename: S J
authors.initials: SJ
authors.lastname: Thompson
authors.forename: C J
authors.initials: CJ
authors.lastname: Elson
mesh_terms: D000818:Animals; D001168:Arthritis / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology* / Q000382:microbiology; D001420:Bacteria, Aerobic / Q000276:immunology* / Q000302:isolation & purification; D001426:Bacterial Proteins / Q000276:immunology; D004198:Disease Susceptibility / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005856:Germ-Free Life; D006360:Heat-Shock Proteins / Q000276:immunology; D007274:Injections, Intraperitoneal; D007422:Intestines / Q000382:microbiology*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA / Q000235:genetics / Q000276:immunology / Q000382:microbiology; D010538:Peritonitis / Q000139:chemically induced* / Q000150:complications; D013047:Specific Pathogen-Free Organisms; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013729:Terpenes / Q000008:administration & dosage / Q000633:toxicity*
chemical_list: D001426:Bacterial Proteins; D006360:Heat-Shock Proteins; D013729:Terpenes; C009042:pristane